Artur Machlenkin
Technik-/Wissenschafts-/F&E-Leiter bei PLURI INC.
Profil
Artur Machlenkin is currently the Chief Scientific Officer at Pluri, Inc. He previously worked as the Chief Executive Officer at Pantheon Biosciences Ltd.
and as the Head-Immuno Oncology at Compugen Usa, Inc. Dr. Machlenkin holds a doctorate degree from the Weizmann Institute of Science.
Aktive Positionen von Artur Machlenkin
| Unternehmen | Position | Beginn |
|---|---|---|
| PLURI INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2022 |
Ehemalige bekannte Positionen von Artur Machlenkin
| Unternehmen | Position | Ende |
|---|---|---|
| Compugen Usa, Inc. | Corporate Officer/Principal | - |
Pantheon Biosciences Ltd.
 Pantheon Biosciences Ltd. Miscellaneous Commercial ServicesCommercial Services Pantheon Biosciences Ltd. is an Israeli company that develops molecular therapies and tools. The company is based in Yavne, Israel and was founded in 2017. | Vorstandsvorsitzender | - |
Ausbildung von Artur Machlenkin
| Weizmann Institute of Science | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PLURI INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Compugen Usa, Inc. | |
Pantheon Biosciences Ltd.
Pantheon Biosciences Ltd. Miscellaneous Commercial ServicesCommercial Services Pantheon Biosciences Ltd. is an Israeli company that develops molecular therapies and tools. The company is based in Yavne, Israel and was founded in 2017. | Commercial Services |
